243 related articles for article (PubMed ID: 8943793)
21. Effects of insulin-like growth factors I and II on oestrone sulphatase activity in human breast cancer cell lines.
Hwa IA; Reimann K; Lim PK; Lai LC
Int J Mol Med; 1999 Aug; 4(2):175-8. PubMed ID: 10402485
[TBL] [Abstract][Full Text] [Related]
22. Control of sulfatase activity by nomegestrol acetate in normal and cancerous human breast tissues.
Chetrite GS; Thomas JL; Shields-Botella J; Cortes-Prieto J; Philippe JC; Pasqualini JR
Anticancer Res; 2005; 25(4):2827-30. PubMed ID: 16080533
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines.
Selcer KW; Hegde PV; Li PK
Cancer Res; 1997 Feb; 57(4):702-7. PubMed ID: 9044848
[TBL] [Abstract][Full Text] [Related]
24. Recent data on estrogen sulfatases and sulfotransferases activities in human breast cancer.
Pasqualini JR; Schatz B; Varin C; Nguyen BL
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):323-9. PubMed ID: 1580921
[TBL] [Abstract][Full Text] [Related]
25. Estrone sulfate-sulfatase and 17 beta-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone-dependence to hormone-independence.
Pasqualini JR; Chetrite G; Nguyen BL; Maloche C; Delalonde L; Talbi M; Feinstein MC; Blacker C; Botella J; Paris J
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):407-12. PubMed ID: 7626488
[TBL] [Abstract][Full Text] [Related]
26. The regulation and inhibition of 17beta-hydroxysteroid dehydrogenase in breast cancer.
Purohit A; Tutill HJ; Day JM; Chander SK; Lawrence HR; Allan GM; Fischer DS; Vicker N; Newman SP; Potter BV; Reed MJ
Mol Cell Endocrinol; 2006 Mar; 248(1-2):199-203. PubMed ID: 16414180
[TBL] [Abstract][Full Text] [Related]
27. Oestrogen sulphatase activity in hormone-dependent and hormone-independent breast-cancer cells: modulation by steroidal and non-steroidal therapeutic agents.
Purohit A; Reed MJ
Int J Cancer; 1992 Apr; 50(6):901-5. PubMed ID: 1532568
[TBL] [Abstract][Full Text] [Related]
28. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
29. Effect of transforming growth factor-beta1 on oestrogen metabolism in MCF-7 and MDA-MB-231 breast cancer cell lines.
Ee YS; Lai LC; Reimann K; Lim PK
Oncol Rep; 1999; 6(4):843-6. PubMed ID: 10373668
[TBL] [Abstract][Full Text] [Related]
30. Progestins and breast cancer.
Pasqualini JR
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():32-41. PubMed ID: 17943537
[TBL] [Abstract][Full Text] [Related]
31. Regulation of aromatase and sulphatase in breast tumour cells.
Purohit A; Wang DY; Ghilchik MW; Reed MJ
J Endocrinol; 1996 Sep; 150 Suppl():S65-71. PubMed ID: 8943789
[TBL] [Abstract][Full Text] [Related]
32. Estradiol inhibits the estrone sulfatase activity in normal and cancerous human breast tissues.
Chetrite GS; Cortes-Prieto JC; Philippe JC; Pasqualini JR
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):289-92. PubMed ID: 17481887
[TBL] [Abstract][Full Text] [Related]
33. Effect of nomegestrol acetate on human estrogen sulfotransferase activity in the hormone-dependent MCF-7 and T-47D breast cancer cell lines.
Chetrite GS; Paris J; Shields-Botella J; Philippe JC; Pasqualini JR
Anticancer Res; 2003; 23(6C):4651-5. PubMed ID: 14981909
[TBL] [Abstract][Full Text] [Related]
34. The role of cytokines and sulphatase inhibitors in regulating oestrogen synthesis in breast tumours.
Reed MJ; Purohit A; Duncan LJ; Singh A; Roberts CJ; Williams GJ; Potter BV
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):413-20. PubMed ID: 7626490
[TBL] [Abstract][Full Text] [Related]
35. Action of danazol on the conversion of estrone sulfate to estradiol and on the sulfatase activity in the MCF-7, T-47D and MDA-MB-231 human mammary cancer cells.
Nguyen BL; Ferme I; Chetrite G; Pasqualini JR
J Steroid Biochem Mol Biol; 1993 Jul; 46(1):17-23. PubMed ID: 8338787
[TBL] [Abstract][Full Text] [Related]
36. Estrogen receptor, growth factor receptor and protooncogene protein activities and possible signal transduction crosstalk in estrogen dependent and independent breast cancer cell lines.
Mohamood AS; Gyles P; Balan KV; Hollis VW; Eckberg WR; Asseffa A; Han Z; Wyche JH; Anderson WA
J Submicrosc Cytol Pathol; 1997 Jan; 29(1):1-17. PubMed ID: 9066137
[TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells.
Prosperi JR; Robertson FM
Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):55-70. PubMed ID: 16997132
[TBL] [Abstract][Full Text] [Related]
38. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
39. Human mammary cancer as a site of sex steroid metabolism.
Vermeulen A
Cancer Surv; 1986; 5(3):585-95. PubMed ID: 3555784
[TBL] [Abstract][Full Text] [Related]
40. Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.
Schindler AE; Bolt HM; Zwirner M; Hochlehnert G; Göser R
Arzneimittelforschung; 1982; 32(7):787-91. PubMed ID: 6289846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]